CLINICAL TRIALS PROFILE FOR CEFTAROLINE FOSAMIL
✉ Email this page to a colleague
All Clinical Trials for Ceftaroline Fosamil
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00633126 ↗ | Pharmacokinetics of Ceftaroline in Subjects 12 to 17 Years of Age | Completed | Forest Laboratories | Phase 1 | 2008-03-01 | The purpose of this study is to determine the pharmacokinetics of ceftaroline in pediatric subjects |
| NCT00633152 ↗ | Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections | Completed | Forest Laboratories | Phase 2 | 2008-02-01 | The purpose of this study is to determine whether ceftaroline is effective and safe in the treatment of complicated skin and skin structure infections in adults. |
| NCT01281462 ↗ | Comparative Study of Coadministered Ceftaroline Fosamil and NXL104 vs. Intravenous Doripenem in Adult Subjects With Complicated Urinary Tract Infections | Completed | Forest Laboratories | Phase 2 | 2010-12-01 | This is a study in adult subjects with complicated urinary tract infection (cUTI) comparing treatment with intravenous (IV) coadministered ceftaroline fosamil and NXL104 versus treatment with IV doripenem. |
| NCT01290900 ↗ | A Single-centre, Randomised, Double-blind, Placebo-controlled, Four Way Crossover Phase I Study to Investigate the Effect on QT/QTc Interval of Ceftazidime NXL104 or Ceftaroline Fosamil NXL104, Compared With Placebo, Using Moxifloxacin (Avelox®) as | Completed | AstraZeneca | Phase 1 | 2011-02-01 | This is a single dose study in healthy male volunteers to investigate the effect of high doses of ceftazidime NXL104 (CAZ104) or ceftaroline fosamil NXL104 (CXL104) on the QT interval |
| NCT01290900 ↗ | A Single-centre, Randomised, Double-blind, Placebo-controlled, Four Way Crossover Phase I Study to Investigate the Effect on QT/QTc Interval of Ceftazidime NXL104 or Ceftaroline Fosamil NXL104, Compared With Placebo, Using Moxifloxacin (Avelox®) as | Completed | Pfizer | Phase 1 | 2011-02-01 | This is a single dose study in healthy male volunteers to investigate the effect of high doses of ceftazidime NXL104 (CAZ104) or ceftaroline fosamil NXL104 (CXL104) on the QT interval |
| NCT01298843 ↗ | Study of Blood Levels of Ceftaroline Fosamil in Children Who Are Receiving Antibiotic Therapy in the Hospital | Completed | Forest Laboratories | Phase 4 | 2011-04-01 | The purpose of this study is to assess blood levels of Ceftaroline fosamil in children. |
| NCT01400867 ↗ | Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections | Completed | AstraZeneca | Phase 2/Phase 3 | 2011-12-01 | This is a study of safety, effectiveness, blood levels and tolerance of Ceftaroline fosamil in children with skin infections receiving antibiotic therapy in the hospital. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Ceftaroline Fosamil
Condition Name
Clinical Trial Locations for Ceftaroline Fosamil
Trials by Country
Clinical Trial Progress for Ceftaroline Fosamil
Clinical Trial Phase
Clinical Trial Sponsors for Ceftaroline Fosamil
Sponsor Name
